
    
      open label, randomized, two-period, two treatment, two sequence, crossover, balanced single
      dose comparative oral bioavailability study in healthy, adult, human subjects under fasting
      conditions.44 healthy, adult, human subjects.There was 11-day interval between treatments.
    
  